AtriCure (NSDQ:ATRC) posted third-quarter results today that beat the consensus forecast on Wall Street and maintained its outlook for the full year. The Mason, Ohio-based atrial fibrillation (AFib) technology developer reported profits of $97.1 million, or $2.11 per diluted share, on sales of $70.5 million for the three months ended Sept. 30. Sales grew 28.7% […]
Conformis misses with Q3 results
Conformis (NSDQ:CFMS) posted third-quarter results today that missed the consensus forecast on Wall Street. The Billerica, Massachusetts-based orthopedic medical device company reported a net loss of $13.0 million, or -$0.07 per share, on sales of $14.3 million for the three months ended Sept. 30. The third-quarter net loss grew 110% compared to Q3 2020, while […]
Abbott pledges funding to increase clinical trial diversity
Abbott Laboratories (NYSE:ABT) today announced $5 million in scholarships to promote diversity in the next generation of clinical trial leaders as part of an initiative to improve healthcare for all. The Abbott Park, Illinois-based developer and manufacturer of medical devices and drugs said its initiative also includes forming the Diversity in Research Medical Advisory Board, […]
Hologic beats the Street after an unprecedented year
Hologic (NSDQ:HOLX) posted fourth-quarter results today that handily beat the consensus forecast on Wall Street, concluding an impressive year of growth on the back of robust COVID-19 testing revenue. The Marlborough, Massachusetts–based diagnostics and women’s health company reported quarterly profits of $328.8 million — or $1.28 per diluted share — on sales of nearly $1.32 […]
Zimmer Biomet’s chief accounting officer is leaving for a new job
Chief Accounting Officer Carrie Nichol is leaving Zimmer Biomet (NYSE:ZBH) effective Nov. 26, the Warsaw, Indiana-based medical device company said on Friday. Nichol also serves as VP, controller and principal accounting officer. She joined Zimmer Biomet in September 2019 from pharma giant Endo International, where she was SVP, controller and chief accounting officer. Get the […]
Philips wants its suppliers to get serious about climate change
Philips (NYSE: PHG) wants at least half of its supply purchasing to come from companies that commit to science-based targets to reduce carbon dioxide emissions by 2025. The health technology company said yesterday that the initiative would be seven times more impactful than Philips’ own carbon dioxide emission reductions. The move comes as medical device […]
Zimmer Biomet introduces OptiVu mixed reality platform, demos new ZBEdge offerings
Zimmer Biomet (NYSE:ZBH) today demonstrated three new ZBEdge offerings connecting robotic and digital healthcare technology. The Warsaw, Indiana-based medical device company started off by introducing its new OptiVu Mixed Reality Solutions platform, which will be used with Microsoft HoloLens smartglasses and three applications available this winter. Get the full story on our sister site, Medical […]
Stryker stock slips on Q3 earnings miss, full-year guidance downgrade
Shares of Stryker (NYSE:SYK) stock slipped today after the company downgraded its full-year outlook and announced third-quarter operating results that missed Wall Street’s expectations. The Kalamazoo, Michigan–based orthopedic device maker posted profits of $438 million, or $1.17 per diluted share, on sales of $4.16 billion for the three months ended Sept. 30, 2021, resulting in […]
Proto Labs stock dives on Q3 earnings miss
Proto Labs (NYSE:PRLB) stock dropped more than 18 percent after the digital manufacturing service provider reported third-quarter earnings that missed Wall Street’s expectations. Maple Plain, Minnesota-based Proto Labs this morning reported earnings of $4.8 million (or 17¢ per share) off sales of $125.3 million. That’s a 67% decrease from Q3 2020’s earnings of $14.7 million (55¢ […]
Edwards Lifesciences reports mixed Q3 financial results
Edwards Lifesciences (NYSE: EW) reported third-quarter financial results that exceeded Wall Street’s expectations on profits but narrowly missed on sales. The Irvine, California–based cardio device company yesterday evening reported earnings of $340.1 million (or 54¢ per share) off sales of $1.31 billion. That’s a 4.6% increase from Q3 2020’s earnings of $325.2 million (52¢ per share) […]
Medtronic faces longer road to renal denervation
Medtronic (NYSE:MDT) will continue the clinical study of its Symplicity Spyral renal denervation (RDN) system for hypertension into next year after lacking the positive results needed to end enrollment early. Fridley, Minnesota-based Medtronic said last month that it hoped to present results of the Spyral HTN-ON MED trial at the Cardiovascular Research Foundation’s TCT Conference in early November, pending […]